These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic. Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312 [TBL] [Abstract][Full Text] [Related]
4. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Malekmohammad K; Rafieian-Kopaei M Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607 [TBL] [Abstract][Full Text] [Related]
5. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection. Khare P; Sahu U; Pandey SC; Samant M Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476 [TBL] [Abstract][Full Text] [Related]
6. Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease. Choudhary S; Nehul S; Singh A; Panda PK; Kumar P; Sharma GK; Tomar S IUBMB Life; 2024 May; 76(5):228-241. PubMed ID: 38059400 [TBL] [Abstract][Full Text] [Related]
7. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies. Azeem M; Mustafa G; Mahrosh HS Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514 [TBL] [Abstract][Full Text] [Related]
8. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease. Hajbabaie R; Harper MT; Rahman T Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721 [TBL] [Abstract][Full Text] [Related]
9. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205 [TBL] [Abstract][Full Text] [Related]
10. Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease. Batool F; Mughal EU; Zia K; Sadiq A; Naeem N; Javid A; Ul-Haq Z; Saeed M J Biomol Struct Dyn; 2022 May; 40(8):3777-3788. PubMed ID: 33251983 [TBL] [Abstract][Full Text] [Related]
14. Computational identification of potential inhibitory compounds in Indian medicinal and aromatic plant species against major pathogenicity determinants of SARS-CoV-2. Sharma S; Sharma A; Bhattacharyya D; Chauhan RS J Biomol Struct Dyn; 2022; 40(24):14096-14114. PubMed ID: 34766880 [TBL] [Abstract][Full Text] [Related]
15. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166 [TBL] [Abstract][Full Text] [Related]